InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Opus Genetics, Inc.

IRD Clue Score33
United States Fiscal year ends December CIK 0001228627 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

60
Insider
Date
Role
Action
Shares
Price
Amount
George Magrath
3 Nov 2026
Chief Executive Officer
Sell
28,258
$3.90
$110.18K
George Magrath
23 Oct 2026
Chief Executive Officer
Sell
9,591
$3.59
$34.38K
Robert E. Gagnon
23 Oct 2026
Chief Financial Officer
Sold on a plan
14,000
$3.55
$49.65K
Benjamin R Yerxa
23 Oct 2026
President
Sell
25,520
$3.53
$90.13K
Benjamin R Yerxa
23 Oct 2026
President
Sell
7,669
$3.55
$27.24K
Joseph K Schachle
23 Oct 2026
Chief Operating Officer
Sell
4,767
$3.57
$16.99K
Foundation Fighting Blindness Retinal Degeneration Fund
30 Sep 2026
Director
Sell
556,000
$4.96
$2.76M
George Magrath
9 Sep 2026
Chief Executive Officer
Exercised, kept
392,157
$1.15
$450.98K
Cam Gallagher
8 Sep 2026
Director
Exercised, kept
784,314
$1.15
$901.96K
Robert E. Gagnon
3 Sep 2026
Chief Financial Officer
Sell
28,000
$4.54
$127.21K
Robert E. Gagnon
23 Jul 2026
Chief Financial Officer
Sell
7,783
$2.95
$22.94K
George Magrath
23 Jul 2026
Chief Executive Officer
Sell
9,475
$2.95
$27.93K
Joseph K Schachle
23 Jul 2026
Chief Operating Officer
Sell
4,644
$2.94
$13.65K
Benjamin R Yerxa
23 Jul 2026
President
Sell
7,429
$2.97
$22.06K
Foundation Fighting Blindness Retinal Degeneration Fund
18 May 2026
Director
Sell
1,700,000
$4.35
$7.40M
Robert E. Gagnon
23 Apr 2026
Chief Financial Officer
Sell
7,842
$5.18
$40.66K
Ashwath Jayagopal
23 Apr 2026
Chief Scientific & Dev. Ofc.
Sell
7,542
$5.19
$39.16K
George Magrath
23 Apr 2026
Chief Executive Officer
Sell
9,511
$5.22
$49.65K
Rabourn Amy Zaremba
23 Apr 2026
Head of Fin. Quality Assurance
Sell
1,641
$5.20
$8.54K
Joseph K Schachle
23 Apr 2026
Chief Operating Officer
Sell
4,697
$5.22
$24.52K
Benjamin R Yerxa
23 Apr 2026
President
Sell
7,470
$5.24
$39.12K
Ashwath Jayagopal
16 Mar 2026
Chief Scientific & Dev. Ofc.
Sell
3,719
$5.12
$19.05K
George Magrath
16 Mar 2026
Chief Executive Officer
Sell
24,438
$5.21
$127.33K
Rabourn Amy Zaremba
16 Mar 2026
Head of Fin. Quality Assurance
Sell
2,816
$5.25
$14.77K
Joseph K Schachle
16 Mar 2026
Chief Operating Officer
Sell
3,719
$5.25
$19.53K
Cam Gallagher
29 Dec 2025
Director
Buy indirect
83,000
$1.97
$163.42K
Cam Gallagher
29 Dec 2025
Director
Buy
81,000
$1.98
$160.27K
Foundation Fighting Blindness Retinal Degeneration Fund
9 Dec 2025
Director
Sell
4,000,000
$2.15
$8.60M
George Magrath
26 Dec 2024
Chief Executive Officer
Buy
100,000
$0.98
$97.60K
Benjamin R Yerxa
21 Nov 2024
President
Buy
10,000
$0.98
$9.83K
George Magrath
18 Nov 2024
Chief Executive Officer
Buy
9,706
$1.02
$9.94K
George Magrath
15 Nov 2024
Chief Executive Officer
Buy
90,294
$1.01
$91.21K
Ashwath Jayagopal
22 May 2024
Chief Scientific & Dev. Ofc.
Buy
3,500
$1.77
$6.18K
George Magrath
17 May 2024
Chief Executive Officer
Buy
5,000
$1.75
$8.77K
Nirav S. Jhaveri
21 Mar 2024
Chief Financial Officer
Buy
10,000
$2.10
$21.00K
Joseph K Schachle
21 Mar 2024
Chief Operating Officer
Buy
2,000
$2.05
$4.10K
George Magrath
18 Mar 2024
Chief Executive Officer
Buy
25,000
$1.96
$49.05K
Cam Gallagher
4 Jan 2023
Director
Exercised, kept
1,574
$0.00
$0.16
Sean Ainsworth
19 Oct 2022
Director
Exercised, kept
1,574
$0.00
$0.16
James S J Manuso
11 Oct 2022
Director
Exercised, kept
787
$0.00
$0.08
Richard J Rodgers
3 Oct 2022
Director
Exercised, kept
3,148
$0.00
$0.31
Mina Sooch
6 Sep 2022
President and CEO
Exercised, kept
1,023
$0.00
$0.10
Mina Sooch
20 May 2022
President and CEO
Buy
12,500
$2.02
$25.30K
James S J Manuso
20 May 2022
Director
Buy
5,000
$1.99
$9.95K
Mina Sooch
19 May 2022
President and CEO
Buy
12,500
$2.07
$25.88K
Jay Pepose
13 Dec 2021
Director
Buy
8,250
$3.65
$30.11K
James S J Manuso
18 Nov 2021
Director
Buy
2,000
$3.50
$7.00K
Jay Pepose
13 Sep 2021
Director
Buy
12,631
$4.75
$60.00K
Susan Benton
2 Sep 2021
Director
Buy
20,000
$4.57
$91.40K
Mina Sooch
19 Nov 2020
President and CEO
Buy
11,524
—
no price
Sean Ainsworth
19 Nov 2020
Director
Buy
8,865
—
no price
Alan R Meyer
19 Nov 2020
Director
Buy
1,771
—
no price
Cam Gallagher
19 Nov 2020
Director
Buy
8,865
—
no price
Richard J Rodgers
19 Nov 2020
Director
Buy
17,730
—
no price
James S J Manuso
19 Nov 2020
Director
Buy
4,434
—
no price
Charles Beever
31 Jan 2019
Director
Buy
10,000
$0.64
$6.38K
Lisa Nolan
30 Jan 2019
Chief Business Officer
Buy
20,000
$0.65
$12.96K
Douglas J Swirsky
29 Jan 2019
President and CEO
Buy
50,000
$0.63
$31.72K
Ben Gil Price
29 Jan 2019
Director
Buy
15,000
$0.61
$9.14K
Chang Ho Ahn
10 Apr 2017
Director
Sold after exercise
250,000
$0.70
$175.38K

What was left out

Form 4 filings counted 231
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 4
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 1
Sales at will 23
Transactions with no price 6
Shares from compensation/vesting 18,098,737
History held since 8 Jan 2007